Report Detail
Global Biologics Market Professional Survey Report 2019
- RnM3743509 |
- 13 September, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Chemical & Material
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The global Biologics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Biologics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biologics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Biologics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Biologics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Segment by Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
Table of Contents
Executive Summary
1 Industry Overview of Biologics
- 1.1 Definition of Biologics
- 1.2 Biologics Segment by Type
- 1.2.1 Global Biologics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Monoclonal Antibodies
- 1.2.3 Vaccines
- 1.2.4 Recombinant Proteins
- 1.2.5 Antisense
- 1.2.6 RNAi
- 1.3 Biologics Segment by Applications
- 1.3.1 Global Biologics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Infectious Diseases
- 1.3.3 Oncology
- 1.3.4 Immunology
- 1.3.5 Autoimmune Diseases
- 1.4 Global Biologics Overall Market
- 1.4.1 Global Biologics Revenue (2014-2025)
- 1.4.2 Global Biologics Production (2014-2025)
- 1.4.3 North America Biologics Status and Prospect (2014-2025)
- 1.4.4 Europe Biologics Status and Prospect (2014-2025)
- 1.4.5 China Biologics Status and Prospect (2014-2025)
- 1.4.6 Japan Biologics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Biologics Status and Prospect (2014-2025)
- 1.4.8 India Biologics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Biologics
- 2.3 Manufacturing Process Analysis of Biologics
- 2.4 Industry Chain Structure of Biologics
3 Development and Manufacturing Plants Analysis of Biologics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Biologics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Biologics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Biologics Production and Capacity Analysis
- 4.2 Biologics Revenue Analysis
- 4.3 Biologics Price Analysis
- 4.4 Market Concentration Degree
5 Biologics Regional Market Analysis
- 5.1 Biologics Production by Regions
- 5.1.1 Global Biologics Production by Regions
- 5.1.2 Global Biologics Revenue by Regions
- 5.2 Biologics Consumption by Regions
- 5.3 North America Biologics Market Analysis
- 5.3.1 North America Biologics Production
- 5.3.2 North America Biologics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Biologics Import and Export
- 5.4 Europe Biologics Market Analysis
- 5.4.1 Europe Biologics Production
- 5.4.2 Europe Biologics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Biologics Import and Export
- 5.5 China Biologics Market Analysis
- 5.5.1 China Biologics Production
- 5.5.2 China Biologics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Biologics Import and Export
- 5.6 Japan Biologics Market Analysis
- 5.6.1 Japan Biologics Production
- 5.6.2 Japan Biologics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Biologics Import and Export
- 5.7 Southeast Asia Biologics Market Analysis
- 5.7.1 Southeast Asia Biologics Production
- 5.7.2 Southeast Asia Biologics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Biologics Import and Export
- 5.8 India Biologics Market Analysis
- 5.8.1 India Biologics Production
- 5.8.2 India Biologics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Biologics Import and Export
6 Biologics Segment Market Analysis (by Type)
- 6.1 Global Biologics Production by Type
- 6.2 Global Biologics Revenue by Type
- 6.3 Biologics Price by Type
7 Biologics Segment Market Analysis (by Application)
- 7.1 Global Biologics Consumption by Application
- 7.2 Global Biologics Consumption Market Share by Application (2014-2019)
8 Biologics Major Manufacturers Analysis
- 8.1 Eli Lilly & Company
- 8.1.1 Eli Lilly & Company Biologics Production Sites and Area Served
- 8.1.2 Eli Lilly & Company Product Introduction, Application and Specification
- 8.1.3 Eli Lilly & Company Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Samsung Biologics
- 8.2.1 Samsung Biologics Biologics Production Sites and Area Served
- 8.2.2 Samsung Biologics Product Introduction, Application and Specification
- 8.2.3 Samsung Biologics Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 F Hoffman La Roche
- 8.3.1 F Hoffman La Roche Biologics Production Sites and Area Served
- 8.3.2 F Hoffman La Roche Product Introduction, Application and Specification
- 8.3.3 F Hoffman La Roche Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Celltrion
- 8.4.1 Celltrion Biologics Production Sites and Area Served
- 8.4.2 Celltrion Product Introduction, Application and Specification
- 8.4.3 Celltrion Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Addgene
- 8.5.1 Addgene Biologics Production Sites and Area Served
- 8.5.2 Addgene Product Introduction, Application and Specification
- 8.5.3 Addgene Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Amgen
- 8.6.1 Amgen Biologics Production Sites and Area Served
- 8.6.2 Amgen Product Introduction, Application and Specification
- 8.6.3 Amgen Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Abbvie Inc.
- 8.7.1 Abbvie Inc. Biologics Production Sites and Area Served
- 8.7.2 Abbvie Inc. Product Introduction, Application and Specification
- 8.7.3 Abbvie Inc. Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sanofi
- 8.8.1 Sanofi Biologics Production Sites and Area Served
- 8.8.2 Sanofi Product Introduction, Application and Specification
- 8.8.3 Sanofi Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Pfizer Inc.
- 8.9.1 Pfizer Inc. Biologics Production Sites and Area Served
- 8.9.2 Pfizer Inc. Product Introduction, Application and Specification
- 8.9.3 Pfizer Inc. Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Merck & Co. Inc.
- 8.10.1 Merck & Co. Inc. Biologics Production Sites and Area Served
- 8.10.2 Merck & Co. Inc. Product Introduction, Application and Specification
- 8.10.3 Merck & Co. Inc. Biologics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Novo Nordisk A/S
- 8.12 Johnson & Johnson Services Inc.
9 Development Trend of Analysis of Biologics Market
- 9.1 Global Biologics Market Trend Analysis
- 9.1.1 Global Biologics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Biologics Regional Market Trend
- 9.2.1 North America Biologics Forecast 2019-2025
- 9.2.2 Europe Biologics Forecast 2019-2025
- 9.2.3 China Biologics Forecast 2019-2025
- 9.2.4 Japan Biologics Forecast 2019-2025
- 9.2.5 Southeast Asia Biologics Forecast 2019-2025
- 9.2.6 India Biologics Forecast 2019-2025
- 9.3 Biologics Market Trend (Product Type)
- 9.4 Biologics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Biologics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Biologics. Industry analysis & Market Report on Biologics is a syndicated market report, published as Global Biologics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
